36th Annual San Antonio Breast Cancer Symposium: resumen de los conceptos clínicos más relevantes

Joaquin Gavilá; María Dolores Torregrosa; Angel Guerrero; Regina Gironés; Amparo Ruiz; Pedro López

doi:10.1016/j.senol.2013.04.001

36th Annual San Antonio Breast Cancer Symposium: resumen de los conceptos clínicos más relevantes

Joaquin Gavilá, María Dolores Torregrosa, Angel Guerrero, Regina Gironés, Amparo Ruiz, Pedro López

Producción científica: Contribución a una revista › Estudio breve › revisión exhaustiva

Resumen

The San Antonio Breast Cancer Symposium, in which breast cancer management is updated from a multidisciplinary perspective, is considered the most important international meeting on breast cancer. Notable contributions this year included 10-year studies of adjuvant tamoxifen and a phase ii trial of letrozole with PD 0332991, a cyclin-dependent kinase 4/6 inhibitor. The present article summarizes, under distinct subheadings, the contributions with greatest clinical impact.

Título traducido de la contribución	36th Annual San Antonio Breast Cancer Symposium: Summary of the contributions with greatest clinical impact
Idioma original	Español
Páginas (desde-hasta)	65-72
Número de páginas	8
Publicación	Revista de Senologia y Patologia Mamaria
Volumen	26
N.º	2
DOI	https://doi.org/10.1016/j.senol.2013.04.001
Estado	Publicada - 2013
Publicado de forma externa	Sí

Palabras clave

Annual San Antonio Breast Cancer Symposium meeting
Breast cancer
Chemotherapy
Radiotherapy

Acceder al documento

10.1016/j.senol.2013.04.001

Otros archivos y enlaces

Enlace a la publicación en Scopus

Citar esto

@article{a9fcbf1138b54618af21da2de871b89f,

title = "36th Annual San Antonio Breast Cancer Symposium: resumen de los conceptos cl{\'i}nicos m{\'a}s relevantes",

abstract = "The San Antonio Breast Cancer Symposium, in which breast cancer management is updated from a multidisciplinary perspective, is considered the most important international meeting on breast cancer. Notable contributions this year included 10-year studies of adjuvant tamoxifen and a phase ii trial of letrozole with PD 0332991, a cyclin-dependent kinase 4/6 inhibitor. The present article summarizes, under distinct subheadings, the contributions with greatest clinical impact.",

keywords = "Annual San Antonio Breast Cancer Symposium meeting, Breast cancer, Chemotherapy, Radiotherapy",

author = "Joaquin Gavil{\'a} and Torregrosa, {Mar{\'i}a Dolores} and Angel Guerrero and Regina Giron{\'e}s and Amparo Ruiz and Pedro L{\'o}pez",

year = "2013",

doi = "10.1016/j.senol.2013.04.001",

language = "Espa{\~n}ol",

volume = "26",

pages = "65--72",

journal = "Revista de Senologia y Patologia Mamaria",

issn = "0214-1582",

number = "2",

}

TY - JOUR

T1 - 36th Annual San Antonio Breast Cancer Symposium

T2 - resumen de los conceptos clínicos más relevantes

AU - Gavilá, Joaquin

AU - Torregrosa, María Dolores

AU - Guerrero, Angel

AU - Gironés, Regina

AU - Ruiz, Amparo

AU - López, Pedro

PY - 2013

Y1 - 2013

N2 - The San Antonio Breast Cancer Symposium, in which breast cancer management is updated from a multidisciplinary perspective, is considered the most important international meeting on breast cancer. Notable contributions this year included 10-year studies of adjuvant tamoxifen and a phase ii trial of letrozole with PD 0332991, a cyclin-dependent kinase 4/6 inhibitor. The present article summarizes, under distinct subheadings, the contributions with greatest clinical impact.

AB - The San Antonio Breast Cancer Symposium, in which breast cancer management is updated from a multidisciplinary perspective, is considered the most important international meeting on breast cancer. Notable contributions this year included 10-year studies of adjuvant tamoxifen and a phase ii trial of letrozole with PD 0332991, a cyclin-dependent kinase 4/6 inhibitor. The present article summarizes, under distinct subheadings, the contributions with greatest clinical impact.

KW - Annual San Antonio Breast Cancer Symposium meeting

KW - Breast cancer

KW - Chemotherapy

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84924220088&partnerID=8YFLogxK

U2 - 10.1016/j.senol.2013.04.001

DO - 10.1016/j.senol.2013.04.001

M3 - Estudio breve

SN - 0214-1582

VL - 26

SP - 65

EP - 72

JO - Revista de Senologia y Patologia Mamaria

JF - Revista de Senologia y Patologia Mamaria

IS - 2

ER -

36th Annual San Antonio Breast Cancer Symposium: resumen de los conceptos clínicos más relevantes

Resumen

Palabras clave

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto